We are live on ! Find out more
AC

Ayrton Capital Portfolio holdings

AUM $14.7M
1-Year Est. Return 12.82%
This Fund
S&P 500
This Quarter Est. Return
-4.84%
1 Year Est. Return
-12.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$57M
AUM Growth
-$4.55M
Cap. Flow
-$5.82M
Cap. Flow %
-10.22%
Top 10 Hldgs %
51.56%
Holding
131
New
10
Increased
1
Reduced
4
Closed
12

Top Buys

Rank Stock Value
1
PMCB icon
PharmaCyte Biotech
PMCB
+$2.23M
2
PAVM icon
PAVmed
PAVM
+$2.01M
3
SLAI
SOLAI Ltd ADS
SLAI
+$191K
4
AYTU icon
AYTU BioPharma
AYTU
+$172K
5
LUCYW icon
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
+$98.9K

Top Sells

Rank Stock Value
1
MMV
MultiMetaVerse Holdings Limited Class A Ordinary Share
MMV
+$1.78M
2
RICO
Agrico Acquisition Corp
RICO
+$668K
3
WARR
Warrior Technologies Acquisition Company
WARR
+$654K
4
GGGV
G3 VRM Acquisition Corp. Class A Common Stock
GGGV
+$347K
5
MOBX icon
Mobix Labs
MOBX
+$126K

Sector Composition

Rank Sector Weight
1 Financials 49.52%
2 Healthcare 19.11%
3 Technology 6.46%
4 Consumer Discretionary 4.18%
5 Communication Services 3.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRMEW
101
DELISTED
VerifyMe, Inc. Warrant
VRMEW
$3K 0.01%
10,000
– –
CLOER
102
DELISTED
Clover Leaf Capital Corp. Rights
CLOER
$3K 0.01%
75,000
– –
AAC.WS
103
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$3K 0.01%
24,851
– –
CHEKZ
104
DELISTED
Check-Cap Ltd. Series C Warrant
CHEKZ
$3K 0.01%
128,151
– –
KALWW
105
DELISTED
Kalera Public Limited Company Warrant
KALWW
$3K 0.01%
+25,000
New +$3.86K
COCHW icon
106
Envoy Medical Warrant
COCHW
$646K
$2K ﹤0.01%
33,333
– –
MOBX icon
107
Mobix Labs
MOBX
$26.7M
$2K ﹤0.01%
3,750
-1,250
-25% -$126K
KACLW
108
DELISTED
Kairous Acquisition Corp. Limited Warrants
KACLW
$2K ﹤0.01%
37,500
– –
APGB.WS
109
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$2K ﹤0.01%
20,000
– –
IBER.WS
110
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
$2K ﹤0.01%
28,393
– –
MSACW
111
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$2K ﹤0.01%
11,111
– –
FVIV.WS
112
DELISTED
Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVIV.WS
$2K ﹤0.01%
12,500
– –
LGACW
113
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$1K ﹤0.01%
20,018
– –
GNLN icon
114
Greenlane Holdings
GNLN
$1.23M
– –
0
– -$30K
MOBXW icon
115
Mobix Labs Warrants
MOBXW
– –
-37,500
Closed -$3K
ABTC
116
American Bitcoin Corp
ABTC
$476M
– –
-30
Closed -$124K
MMV
117
DELISTED
MultiMetaVerse Holdings Limited Class A Ordinary Share
MMV
– –
-175,038
Closed -$1.78M
RCHGW
118
DELISTED
Recharge Acquisition Corp. Warrant
RCHGW
$0 ﹤0.01%
25,000
– –
NBEV
119
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
– –
-234,387
Closed -$53K
WARR.WS
120
DELISTED
Warrior Technologies Acquisition Company Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
WARR.WS
– –
-41,961
Closed -$2K
WARR
121
DELISTED
Warrior Technologies Acquisition Company
WARR
– –
-65,802
Closed -$654K
CRXT
122
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
– –
-32,525
Closed -$12K
GGGV
123
DELISTED
G3 VRM Acquisition Corp. Class A Common Stock
GGGV
– –
-34,200
Closed -$347K
GGGVR
124
DELISTED
G3 VRM Acquisition Corp. Rights
GGGVR
– –
-60,000
Closed -$6K
RICO
125
DELISTED
Agrico Acquisition Corp
RICO
– –
-50,000
Closed -$668K
2 3 4
5
6

Similar funds

VVA
Vintage Ventures Advisors Herzliya, Israel $15.2M AUM 35.41% 1-Year Est. Return
AR
Acacia Research New York $14.1M AUM 50.98% 1-Year Est. Return
TAM
Toscafund Asset Management London, United Kingdom $15.6M AUM 12.56% 1-Year Est. Return
RCGI
Ribbit Capital GP IV Palo Alto, California $15.6M AUM 103.62% 1-Year Est. Return
AEM
ACON Equity Management Washington, District of Columbia $13.8M AUM 62.17% 1-Year Est. Return
CAM
Connacht Asset Management New York $16.9M AUM 40.41% 1-Year Est. Return
HMP9
Highland Management Partners 9 Cambridge, Massachusetts $12.6M AUM 85.13% 1-Year Est. Return
LM
Lockheed Martin Bethesda, Maryland $12.1M AUM 46.13% 1-Year Est. Return

Ayrton Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Ayrton Capital held 131 positions worth $57M, down 7.4% from $61.6M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Ayrton Capital withdrew a net $5.82M in Q3 2022, closing 12 positions and reducing 4 holdings. Its most notable exit was MultiMetaVerse Holdings Limited Class A Ordinary Share, an estimated $1.78M position sold in full.

By sector, the portfolio is most concentrated in Financials at 50% of assets, down from 54% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Ayrton Capital opened a new position in PAVmed worth $1.38M.

  • Ayrton Capital's largest Q3 2022 buy was PAVmed: 3,555 shares worth $1.38M.
  • Ayrton Capital added most to PharmaCyte Biotech in Q3 2022, an estimated $2.23M increase.
  • Ayrton Capital's biggest Q3 2022 reduction was Mobix Labs, cutting an estimated $126K.
  • Ayrton Capital fully exited MultiMetaVerse Holdings Limited Class A Ordinary Share in Q3 2022, selling an estimated $1.78M.
  • Ayrton Capital's ten largest holdings make up 52% of its $57M portfolio in Q3 2022.
  • Ayrton Capital opened 10 new positions and closed 12 in Q3 2022.
  • Ayrton Capital's portfolio value fell 7.4% quarter-over-quarter to $57M.

Based on Ayrton Capital's 13F filing for Q3 2022, filed 9 Nov 2022.